Syros Pharmaceuticals Inc. (SYRS) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Syros Pharmaceuticals Inc. (SYRS:NASDAQ), powered by AI.

Current Price
$0.00
Market Cap
5,665
Sector
Healthcare
What is the Syros Pharmaceuticals Inc. stock price forecast?

Syros Pharmaceuticals Inc. is currently trading at $0.00. View real-time AI analysis on Alpha Lenz.

What is Syros Pharmaceuticals Inc. insider trading activity?

View the latest insider trading data for Syros Pharmaceuticals Inc. on Alpha Lenz.

What is Syros Pharmaceuticals Inc.'s P/E ratio?

View Syros Pharmaceuticals Inc.'s valuation metrics on Alpha Lenz.

Syros Pharmaceuticals Inc.

NASDAQ · SYRS
$0.00
Ask about Syros Pharmaceuticals Inc.'s future dividend policy...
Alpha Chat Insight

Syros Pharmaceuticals Inc.'s ROE is -227.9%. Explore profitability and growth together.

Ask for details

Company Overview

Syros Pharmaceuticals Inc. is a biopharmaceutical company that focuses on discovering and developing medicines to control the expression of genes with the goal of treating diseases. The primary function of Syros Pharmaceuticals is to leverage its proprietary platform to identify and target gene regulatory regions to create therapeutics for cancer and other challenging diseases. Key features of the company include its emphasis on precision medicine, using gene regulatory analysis to pioneer drug discovery and development. Syros Pharmaceuticals plays a crucial role in the biotechnology sector by expanding treatment options for conditions that are currently underserved by existing therapies. Its innovative approach is redefining how genetic medicine can be applied to modern healthcare problems. Based in Cambridge, Massachusetts, Syros aims to produce novel therapeutics that address the underlying causes of disease, offering hope for patients through its groundbreaking scientific research and development.

CEOMr. Gerald E. Quirk Esq., J.D.
SectorHealthcare
IndustryBiotechnology
Employees68

Company Statistics

FY 2023

Profile

$5.67KMarket Cap
$9.94MRevenue
0.00Shares Out
68Employees

Margins

N/AGross
-1181.87%EBITDA
-1273.14%Operating
-1656.34%Pre-Tax
-1656.34%Net

Valuation

N/AP/E
0.00P/B
0.00EV/Sales
0.66EV/EBITDA
-0.00P/FCF

Growth (CAGR)

-13.01%Rev 3Yr
37.12%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-79.76%ROA
-227.94%ROE
-77.28%ROIC

Financial Health

$139.53MCash & Cash Equivalents
$11.99MNet Debt
909.33%Debt/Equity
N/AInterest Cov
Alpha Chat Insight

Syros Pharmaceuticals Inc.'s ROE is -227.9%. Explore profitability and growth together.

Ask for details

Frequently Asked Questions

Syros Pharmaceuticals Inc. (ticker: SYRS) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 68 employees. Market cap is $5,665.

The current price is $0 with a P/E ratio of -x and P/B of 0x.

ROE is -227.94% and operating margin is -1273.14%. Annual revenue is $10M.

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
Syros Pharmaceuticals Inc. (Healthcare) Stock Forecast & Analysis $0.00 | Alpha Lenz